Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Bolni Nagalo

Concepts (204)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Blood Donors
11
2021
31
4.010
Why?
Hepatitis B
8
2023
23
2.170
Why?
Oncolytic Virotherapy
3
2022
16
1.730
Why?
HIV Infections
11
2021
354
1.620
Why?
Hepatitis B Surface Antigens
4
2018
9
1.550
Why?
Syphilis
7
2019
25
1.350
Why?
Carcinoma, Hepatocellular
4
2023
194
1.180
Why?
Hepatitis C
5
2021
77
1.160
Why?
Blood Transfusion
3
2021
121
1.160
Why?
Liver Neoplasms
4
2023
332
1.080
Why?
Seroepidemiologic Studies
10
2021
43
0.930
Why?
Burkina Faso
16
2023
16
0.910
Why?
Vesicular Stomatitis
1
2022
1
0.850
Why?
Enzyme-Linked Immunosorbent Assay
4
2018
245
0.770
Why?
Biliary Tract Neoplasms
4
2022
8
0.750
Why?
HIV Antibodies
1
2018
10
0.660
Why?
Blood-Borne Pathogens
1
2018
7
0.650
Why?
HIV-1
4
2018
55
0.600
Why?
Gabon
4
2019
4
0.530
Why?
Mass Screening
1
2018
351
0.510
Why?
Rural Population
1
2018
535
0.470
Why?
Young Adult
11
2021
3936
0.460
Why?
Skin Neoplasms
3
2024
487
0.440
Why?
HIV Seroprevalence
2
2014
4
0.430
Why?
Vesiculovirus
2
2022
5
0.430
Why?
Humans
35
2024
49827
0.420
Why?
Cholangiocarcinoma
2
2022
27
0.400
Why?
Bile Duct Neoplasms
2
2022
30
0.400
Why?
Adolescent
10
2021
6340
0.390
Why?
Antibodies, Viral
1
2011
88
0.390
Why?
Adult
16
2021
13160
0.380
Why?
Plasma
1
2011
43
0.380
Why?
Communicable Diseases
1
2011
55
0.370
Why?
Melanoma
2
2024
284
0.330
Why?
Prevalence
6
2018
943
0.290
Why?
Female
17
2021
26329
0.280
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2022
987
0.280
Why?
Middle Aged
12
2020
11997
0.280
Why?
Male
14
2021
25093
0.270
Why?
Sensitivity and Specificity
2
2018
854
0.270
Why?
Hepacivirus
2
2018
103
0.260
Why?
Cell Proliferation
4
2024
1007
0.240
Why?
Molecular Docking Simulation
2
2023
73
0.240
Why?
Monophenol Monooxygenase
1
2023
5
0.230
Why?
Cell Line, Tumor
3
2024
1402
0.230
Why?
Antineoplastic Agents
2
2024
1172
0.230
Why?
Incidence
2
2021
1003
0.230
Why?
Carcinoma, Pancreatic Ductal
1
2024
30
0.230
Why?
Anti-HIV Agents
2
2014
42
0.230
Why?
Drug Synergism
2
2021
150
0.220
Why?
Hepatitis B virus
2
2023
27
0.220
Why?
Psoriasis
1
2023
30
0.210
Why?
Vesicular stomatitis Indiana virus
1
2022
2
0.210
Why?
Dermatitis
1
2023
36
0.210
Why?
Animals
6
2023
13150
0.210
Why?
Antioxidants
2
2023
248
0.200
Why?
Students, Medical
1
2023
159
0.190
Why?
Treponema pallidum
2
2018
10
0.190
Why?
Flavonols
1
2020
4
0.190
Why?
Pancreatic Neoplasms
1
2024
213
0.190
Why?
Viral Proteins
1
2022
155
0.190
Why?
Risk Factors
4
2020
3619
0.190
Why?
Disease Models, Animal
2
2023
1451
0.180
Why?
Cymbopogon
1
2020
1
0.180
Why?
Oils, Volatile
1
2020
12
0.180
Why?
Immunotherapy
2
2021
238
0.180
Why?
Receptors, KIR
1
2019
13
0.180
Why?
Sequence Deletion
1
2020
67
0.180
Why?
Protein Kinase Inhibitors
1
2021
202
0.180
Why?
Mice
4
2023
5720
0.170
Why?
Plasma Membrane Calcium-Transporting ATPases
1
2019
2
0.170
Why?
Glutathione Transferase
1
2020
174
0.170
Why?
Retrospective Studies
6
2022
6117
0.170
Why?
Polymorphism, Genetic
1
2020
181
0.170
Why?
Virology
1
2018
6
0.160
Why?
HIV
1
2018
24
0.160
Why?
Anti-Inflammatory Agents
1
2020
162
0.160
Why?
Aged
6
2022
9272
0.160
Why?
Molecular Structure
3
2024
297
0.150
Why?
Immunotherapy, Adoptive
1
2018
154
0.140
Why?
Blood Pressure
1
2019
514
0.140
Why?
Polymorphism, Single Nucleotide
1
2019
485
0.140
Why?
Odds Ratio
1
2018
548
0.140
Why?
T-Lymphocytes
1
2018
338
0.130
Why?
Cross-Sectional Studies
2
2018
1541
0.130
Why?
Polymerase Chain Reaction
2
2014
455
0.130
Why?
Cisplatin
3
2022
278
0.130
Why?
HIV-2
1
2014
1
0.130
Why?
Hospitals, Military
1
2014
7
0.130
Why?
Time Factors
2
2018
2912
0.120
Why?
Drug Monitoring
1
2014
77
0.120
Why?
Syphilis Serodiagnosis
1
2014
4
0.120
Why?
Antibodies, Monoclonal
1
2018
458
0.120
Why?
RNA, Viral
2
2014
125
0.120
Why?
Peritonitis
1
2014
27
0.120
Why?
Community-Acquired Infections
1
2014
38
0.120
Why?
Immunocompromised Host
1
2014
120
0.120
Why?
Genotype
3
2023
538
0.120
Why?
Viremia
1
2014
22
0.120
Why?
Neoplasms
1
2023
1233
0.110
Why?
Genetic Predisposition to Disease
3
2023
510
0.110
Why?
Meningitis, Bacterial
1
2013
6
0.110
Why?
Infectious Disease Transmission, Vertical
1
2012
15
0.110
Why?
Rubella
1
2012
4
0.110
Why?
Antiretroviral Therapy, Highly Active
1
2012
34
0.110
Why?
Toxoplasmosis
1
2012
15
0.110
Why?
Antibodies, Protozoan
1
2012
12
0.110
Why?
Gene Frequency
2
2023
94
0.110
Why?
Bacteria
1
2014
223
0.100
Why?
Case-Control Studies
3
2020
1128
0.100
Why?
Real-Time Polymerase Chain Reaction
1
2013
181
0.100
Why?
Bile Ducts, Intrahepatic
2
2022
16
0.100
Why?
Pilot Projects
2
2013
699
0.100
Why?
Drug Screening Assays, Antitumor
2
2024
136
0.100
Why?
Apoptosis
3
2024
1100
0.100
Why?
TOR Serine-Threonine Kinases
2
2023
77
0.100
Why?
Pregnancy Complications, Infectious
1
2012
73
0.100
Why?
Structure-Activity Relationship
2
2024
394
0.100
Why?
Deoxycytidine
2
2021
27
0.100
Why?
Tumor Microenvironment
2
2024
210
0.090
Why?
Hospitals, Teaching
1
2011
53
0.090
Why?
Autophagy
2
2023
168
0.090
Why?
Xenograft Model Antitumor Assays
2
2021
210
0.090
Why?
Programmed Cell Death 1 Receptor
2
2021
38
0.090
Why?
Tumor Cells, Cultured
2
2020
465
0.090
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2011
595
0.090
Why?
Prospective Studies
2
2012
2344
0.080
Why?
Anti-Bacterial Agents
1
2014
743
0.080
Why?
rho-Associated Kinases
1
2024
20
0.060
Why?
Hedgehog Proteins
1
2024
33
0.060
Why?
Blood Banks
2
2014
18
0.060
Why?
Azoles
1
2023
28
0.060
Why?
Immunomodulation
1
2024
37
0.060
Why?
HLA-DRB1 Chains
1
2023
4
0.060
Why?
Research
1
2023
112
0.050
Why?
HLA Antigens
1
2023
51
0.050
Why?
Interleukin-17
1
2023
36
0.050
Why?
Pyrazoles
1
2023
113
0.050
Why?
Medical Oncology
1
2023
96
0.050
Why?
Computer Simulation
1
2023
282
0.050
Why?
Platinum
1
2022
11
0.050
Why?
Sirolimus
1
2023
62
0.050
Why?
Alleles
1
2023
251
0.050
Why?
Clone Cells
1
2022
74
0.050
Why?
Proto-Oncogene Proteins c-akt
1
2023
157
0.050
Why?
Cyclin-Dependent Kinase 6
1
2021
2
0.050
Why?
Phosphatidylinositol 3-Kinases
1
2023
141
0.050
Why?
Cyclin-Dependent Kinase 4
1
2021
11
0.050
Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2021
11
0.050
Why?
Program Evaluation
1
2023
349
0.050
Why?
Pregnancy
3
2014
2584
0.050
Why?
Enzyme Inhibitors
1
2023
391
0.050
Why?
Cyclin-Dependent Kinase 2
1
2020
16
0.050
Why?
Proto-Oncogene Proteins c-kit
1
2020
36
0.050
Why?
Liver Cirrhosis
1
2023
218
0.050
Why?
Cytidine Monophosphate
1
2020
1
0.050
Why?
Curriculum
1
2023
404
0.050
Why?
Flame Ionization
1
2020
3
0.050
Why?
Medicine, Traditional
1
2020
18
0.050
Why?
Mice, Inbred NOD
1
2020
96
0.040
Why?
Plant Leaves
1
2020
43
0.040
Why?
Gas Chromatography-Mass Spectrometry
1
2020
67
0.040
Why?
Mice, SCID
1
2020
175
0.040
Why?
Aldehydes
1
2020
83
0.040
Why?
Cytokines
1
2023
612
0.040
Why?
Genomics
1
2021
282
0.040
Why?
Lipids
1
2020
147
0.040
Why?
DNA, Viral
1
2019
133
0.040
Why?
Sesquiterpenes
1
2020
90
0.040
Why?
Cell Survival
1
2020
598
0.040
Why?
Cohort Studies
1
2023
1422
0.040
Why?
Immunohistochemistry
1
2021
971
0.040
Why?
Genetic Association Studies
1
2019
116
0.040
Why?
Inflammation
1
2023
604
0.040
Why?
CTLA-4 Antigen
1
2018
25
0.040
Why?
Alcohol Drinking
1
2020
223
0.040
Why?
Neoplasm Recurrence, Local
1
2021
618
0.040
Why?
Dose-Response Relationship, Drug
1
2020
1374
0.040
Why?
Signal Transduction
1
2024
1617
0.040
Why?
Body Mass Index
1
2020
652
0.040
Why?
Phenotype
1
2019
727
0.030
Why?
Smoking
1
2020
510
0.030
Why?
CD4 Lymphocyte Count
1
2014
32
0.030
Why?
Aged, 80 and over
1
2022
3125
0.030
Why?
Opportunistic Infections
1
2014
59
0.030
Why?
Risk Assessment
1
2019
1262
0.030
Why?
Reagent Kits, Diagnostic
1
2014
18
0.030
Why?
Genotyping Techniques
1
2014
20
0.030
Why?
Hepatitis C Antibodies
1
2014
20
0.030
Why?
Donor Selection
1
2014
12
0.030
Why?
Drug Resistance, Bacterial
1
2014
71
0.030
Why?
Drug Therapy, Combination
1
2014
378
0.030
Why?
Weight Gain
1
2014
240
0.030
Why?
Microbial Sensitivity Tests
1
2014
271
0.030
Why?
Pregnancy Complications, Parasitic
1
2012
4
0.030
Why?
Antibodies, Anti-Idiotypic
1
2012
19
0.030
Why?
Molecular Diagnostic Techniques
1
2013
32
0.030
Why?
Water
1
2012
76
0.030
Why?
Disease Progression
1
2014
822
0.030
Why?
Comorbidity
1
2014
618
0.020
Why?
Socioeconomic Factors
1
2012
580
0.020
Why?
Follow-Up Studies
1
2014
2179
0.020
Why?
Treatment Outcome
1
2014
5138
0.010
Why?
Child
1
2012
6824
0.010
Why?
Nagalo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description